Advertisement
+ News Categories + Corporate Categories + Report Categories

NEXT ARTICLE

Small-Cap Stock Trade Review: Canadian Solar Report featured on MicroStockProfit.com

19:00 EST 20 Dec 2011 | Globe Newswire

DALLAS, Dec. 21, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring Canadian Solar Inc. (Nasdaq:CSIQ). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart

Related Biotechnology, Pharmaceutical and Healthcare News

MicroStockProfit.com is the premier destination for investment information, making your trading decisions easier than ever. Get the rundown on how CSIQ stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for CSIQ at: http://www.microstockprofit.com/lp/CSIQ

This newsletter has been helping traders make great investment decisions on CSIQ; click here for a 15% discount offer.

In the report, the analyst notes:

"Shares of Canadian Solar Inc. (CSIQ) jumped as much as 42% to $3.13 Tuesday, boosted by news that its wholly owned subsidiary, Canadian Solar Solutions Inc., has inked a sales deal with TransCanada Corp., whereby TransCanada will acquire from the Company an 86 megawatt AC solar project portfolio for about 470 million Canadian dollars."

"CSIQ reported net revenue of $499.6 million for the third quarter of 2011, up 3.7% from $481.8 million for the second quarter of 2011 and up 32.5% from $377.2 million for the third quarter of 2010."

To read the entire report visit: www.microstockprofit.com/lp/CSIQ

See what investors are saying about CSIQ at http://www.stockhideout.com

Get breaking news on CSIQ at http://thestockmarketwatch.com/

MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

CONTACT: Brittany Webster
         info@microstockprofit.com
         1-888-307-2850

Globe Newswire

 Channels 70 Associated Channels :: Search

  • Solar urticaria

  • Diverticular Disease of the Stomach and Small Bowel

  • Staphylococcal aureus infections

    Staphylococcal aureus infections represent an enormous burden to public health systems. Traditionally restricted to the hospital setting as nosocomial infections, highly virulent strains have recently...

  • Phosphodiesterase 4 PDE 4 Inhibitors

    Phosphodiesterase 4 (PDE-4) inhibitors have attracted considerable interest as potential therapeutic agents for diseases including chronic obstructive pulmonary disease. PDE-4 inhibitors are known to...

  • Prevacid

    Prevacid, produced by Takeda Pharmaceuticals North America, Inc netted $2.5 in sales in 2009, the 10th highest in the world. Prevacid, the trade name for lansoprazole, is a proton pump inhibitor d...

  • Proteasome Inhibitors

    The proteasome is involved in many essential cellular functions, such as regulation of cell cycle, cell differentiation, signal transduction pathways, antigen processing for appropriate immune respon...

  • Lung Cancer

    Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common ca...

  • CurrentPartnering

    CurrentPartnering was established in 2007 to offer an objective and informal business tool for business development executives, providing an opportunity for the dissemination of the latest trends in...

  • Gout - news, views, blogs

    According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common f...

  • Michigan

    Surrounded by the Great Lakes in the north east of the US, Michigan hosts many high profile biotechnology companies and has become an industry hotbed. In 1993 MichBio was formed, as an industry tr...

Associated Content for this Article